Chuanqi Wei

673 total citations
15 papers, 517 citations indexed

About

Chuanqi Wei is a scholar working on Molecular Medicine, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chuanqi Wei has authored 15 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 6 papers in Pharmacology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chuanqi Wei's work include Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). Chuanqi Wei is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). Chuanqi Wei collaborates with scholars based in China, Germany and Philippines. Chuanqi Wei's co-authors include Wentao Ni, Junchang Cui, You-ning Liu, Jin Zhao, Rui Wang, Yuliang Han, Faping Wang, Rui Wang, Fengming Luo and Xiaoju Tang and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Medicine.

In The Last Decade

Chuanqi Wei

14 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanqi Wei China 10 264 157 140 104 85 15 517
Vasiliki Koumaki Greece 12 412 1.6× 124 0.8× 184 1.3× 102 1.0× 7 0.1× 41 615
Fabrizio Taglietti Italy 13 206 0.8× 68 0.4× 168 1.2× 188 1.8× 27 0.3× 32 646
Ludovic Cabanne France 10 227 0.9× 62 0.4× 83 0.6× 165 1.6× 20 0.2× 16 529
Zijuan Jian China 12 227 0.9× 37 0.2× 112 0.8× 80 0.8× 10 0.1× 35 423
Duck Jin Hong South Korea 11 227 0.9× 62 0.4× 63 0.5× 127 1.2× 38 0.4× 16 612
Özay Arıkan Akan Türkiye 9 248 0.9× 53 0.3× 155 1.1× 136 1.3× 27 0.3× 27 478
Yake Yao China 11 116 0.4× 27 0.2× 43 0.3× 142 1.4× 97 1.1× 38 436
Juan Alcalá Spain 5 274 1.0× 63 0.4× 89 0.6× 230 2.2× 12 0.1× 5 374
H. Sprecher Israel 14 271 1.0× 123 0.8× 80 0.6× 265 2.5× 25 0.3× 18 546
J Texier-Maugein France 13 102 0.4× 77 0.5× 28 0.2× 214 2.1× 13 0.2× 29 427

Countries citing papers authored by Chuanqi Wei

Since Specialization
Citations

This map shows the geographic impact of Chuanqi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanqi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanqi Wei more than expected).

Fields of papers citing papers by Chuanqi Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanqi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanqi Wei. The network helps show where Chuanqi Wei may publish in the future.

Co-authorship network of co-authors of Chuanqi Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanqi Wei. A scholar is included among the top collaborators of Chuanqi Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanqi Wei. Chuanqi Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tang, Shijie, Chuanqi Wei, Xiaoyu Wang, et al.. (2023). Birt-Hogg-Dubé syndrome with c.1579_1580insA variant in a Chinese family: a case report. Frontiers in Medicine. 10. 1184854–1184854. 1 indexed citations
3.
Wei, Chuanqi, Xiaoju Tang, Faping Wang, et al.. (2019). Molecular characterization of pulmonary defenses against bacterial invasion in allergic asthma: The role of Foxa2 in regulation of β-defensin 1. PLoS ONE. 14(12). e0226517–e0226517. 7 indexed citations
4.
Chen, Bojiang, Faping Wang, Chuanqi Wei, et al.. (2019). A Higher Rate of Pulmonary Fungal Infection in Chronic Obstructive Pulmonary Disease Patients with Influenza in a Large Tertiary Hospital. Respiration. 98(5). 391–400. 9 indexed citations
5.
Wang, Faping, et al.. (2018). Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis. Journal of Dermatological Science. 90(2). 190–198. 53 indexed citations
7.
Zhao, Jin, Yubin Xing, Wei Liu, et al.. (2016). Surveillance of Dihydropteroate Synthase Genes in Stenotrophomonas maltophilia by LAMP: Implications for Infection Control and Initial Therapy. Frontiers in Microbiology. 7. 1723–1723. 8 indexed citations
9.
Ni, Wentao, Yuliang Han, Chuanqi Wei, et al.. (2016). Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections. Medicine. 95(11). e3126–e3126. 88 indexed citations
10.
Ni, Wentao, Chuanqi Wei, Beibei Liang, et al.. (2016). Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae. Frontiers in Microbiology. 7. 1304–1304. 19 indexed citations
11.
Ni, Wentao, Yuliang Han, Jin Zhao, et al.. (2015). Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. International Journal of Antimicrobial Agents. 47(2). 107–116. 77 indexed citations
12.
Ni, Wentao, et al.. (2015). Efficacy of polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. The Brazilian Journal of Infectious Diseases. 19(2). 170–180. 32 indexed citations
13.
Ni, Wentao, et al.. (2015). Prophylactic Use of Macrolide Antibiotics for the Prevention of Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis. PLoS ONE. 10(3). e0121257–e0121257. 77 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026